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Abstract
 y.The superoxide O -generating NADPH oxidase of phagocytic cells is composed of a membrane-bound flavocy-2
 .  .tochrome cytochrome b-559 and three cytosolic components, p47-phox, p67-phox, and the small GTPase rac-1 or 2 .
 .Cytochrome b-559 bears the NADPH binding site and the redox centers FAD and heme . Electron flow through the redox
centers, from NADPH to oxygen, is activated consequent to the assembly of the three cytosolic components with
cytochrome b-559. We studied the kinetics of electron flow through the redox centers of NADPH oxidase in a cell-free
system, consisting of purified relipidated and reflavinated cytochrome b-559 and recombinant cytosolic components,
activated by the anionic amphiphile, lithium dodecyl sulphate. The NADPH oxidase complex assembled in vitro exhibited:
 .  .  . a a high steady-state electron flow 165 electronsrhemers ; b low stationary levels of FAD and heme reduction about
.  .  y1 .10% , and c a high rate constant of heme oxidation by oxygen 1720 s . Surprisingly, the kinetic properties of NADPH
 y.oxidase assembled in a semi-recombinant cell-free system, lacking p47-phox found to generate significant amounts of O ,2
were similar to those of the complete system, as shown by a steady-state electron flow of 83 electronsrhemers, low
 . y1stationary levels of FAD and heme reduction 10% , and a rate constant of heme oxidation by oxygen of 1455 s . The
kinetic features of NADPH oxidase assembled in vitro from purified and recombinant components differ considerably from
those of solubilized enzyme preparations derived from intact stimulated phagocytes. The fast operation of the cell-free
system is best explained by the activation-related facilitation of electron flow at both the FAD“heme and the
heme“oxygen steps.
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Abbreviations: Oy, superoxide; PMA, phorbol 12-myristate2
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1. Introduction
 y.Phagocytes produce superoxide O in response2
to triggering of membrane receptors by certain stim-
uli. Oy is generated by the NADPH-derived one-2
electron reduction of molecular oxygen, a reaction
catalysed by a heterodimeric, membrane-bound flavo-
 . cytochrome cytochrome b-559 reviewed in Refs.
w x.1–5 . Electron transfer from NADPH to oxygen is
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activated following interaction of cytochrome b-559
with three cytosolic proteins, p47-phox, p67-phox
and the small GTPase rac-1 or rac-2, resulting in the
assembly of a multimolecular structure, known as the
 w x.NADPH oxidase complex reviewed in Refs. 5,6 .
Cytochrome b-559 represents the only catalytic com-
ponent of the complex, containing both redox centers
 . w xFAD and heme 7–9 , and interaction with the
cytosolic components is thought to activate electron
transfer through the pathway NADPH“FAD“
heme“O , as proposed originally by Cross et al.2
w x2,10 .
The main argument in favor of this scheme is
provided by steady-state kinetic investigations, per-
mitting the determination of the stationary reduction
levels of the redox carriers in the flavocytochrome
and of the rate constants of its interaction with oxy-
gen. Earlier studies were performed on solubilized
w x w xmembranes derived from pig 11 or human 12
neutrophils stimulated, while intact, with phorbol
 .12-myristate 13-acetate PMA . Such preparations
possessed low turnover rates, ranging from 11 to 13
electronsrs. The long time elapsed from the activa-
tion of NADPH oxidase to the performance of kinetic
measurements and the numerous steps required for
obtaining solubilized material for study raise ques-
tions about the relation of results obtained with such
preparations to the kinetic parameters of the activated
enzyme functioning in the intact cell.
NADPH oxidase activation can be mimicked in
vitro by a cell-free system, consisting of components,
derived from unstimulated phagocytes, exposed to a
critical concentration of an anionic amphiphile, such
w xas arachidonate or dodecyl sulphate 13,14 . In its
most advanced form, NADPH-dependent Oy genera-2
tion is induced in vitro in a mixture of purified
cytochrome b-559 and recombinant cytosolic compo-
w xnents 15 . The semi-recombinant cell-free system
offers ideal conditions for the performance of kinetic
measurements, resulting from our ability to optimize
the concentration of individual NADPH oxidase com-
ponents, the lipid environment and state of reflavina-
tion of cytochrome b-559, as well as the intensity and
duration of activation. Turnover values assessed in an
optimally activated cell-free system about 150 elec-
. w xtronsrs 7,15–17 are 10-fold higher than those
found in membrane extracts of stimulated cells. With
w xone exception 16 , no in-depth kinetic study of the
reduction of redox centers of the NADPH oxidase
complex assembled in vitro has been performed.
The present communication describes the charac-
teristics of electron transfer in an NADPH oxidase
complex assembled in vitro from purified cytochrome
b-559 and recombinant cytosolic components p47-
phox, p67-phox, and rac-1. At the methodological
level, the present study is based on the use of diode-
array spectrophotometry, providing fast simultaneous
monitoring of the overall electron flow through the
NADPH oxidase complex and of the redox state of
electron carriers within it.
2. Materials and methods
2.1. Cytochrome b-559 purification
Cytochrome b-559 was purified and incorporated
w xinto liposomes essentially as described before 17,18 .
 .Briefly, the high-speed 100 000=g sedimented
fraction of guinea pig peritoneal macrophage mem-
branes, prewashed with 1.5 M NaCl, was solubilized
with 50 mM n-octyl-b-D-glucopyranoside in buffer A
 w x50 mM sodium phosphate pH 7.4 , 1 mM MgCl , 12
mM EGTA, 1 mM phenylmethylsulfonylfluoride, 1
.mgrml leupeptin and 20% glycerol . This was fol-
lowed by affinity chromatography on heparin-agarose
and resulted in cytochrome preparations with a spe-
cific content of 4–6 nmol hemermg protein. The
material was concentrated by ultrafiltration to a con-
centration of 1–3 mM, supplemented with 200
mgrml phospholipid L-a-phosphatidylcholine, type
.IV-S, Sigma and dialyzed against detergent-free
buffer A. The resulting cytochrome b-559-containing
liposomes were kept until use at y758C.
2.2. Preparation of recombinant cytosolic NADPH
oxidase components
Baculoviruses carrying the cDNAs for human
p47-phox and p67-phox were kind gifts of Dr.
Thomas L. Leto. Suspension cultures of Sf9 cells
 6 .2=10 cellsrml , grown in serum-free medium
 .SF-900 II SFM, Life Technologies were infected
with the recombinant baculoviruses and harvested 72
h after infection. The recombinant proteins were pre-
w xpared as described by Leto et al. 19 , with some
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modifications. Briefly, the cells were disrupted using
 .a 250 W sonicator 3 pulses of 30 s , centrifuged at
12 000 = g and the supernatant fractions recen-
trifuged at 100 000=g for 1 h. The high speed
 .supernatants referred to as ‘crude extract’ were
subjected to ion exchange chromatography in order to
purify the recombinant proteins. Crude extract, con-
taining p47-phox, was applied to a SP Sepharose
 .column HiLoad 16r10, Pharmacia Biotech , equili-
brated with 50 mM sodium phosphate buffer pH
.7.0 , supplemented with 1 mM dithioerythritol, and
was eluted with a 0–0.3 M NaCl gradient in the same
 .buffer 210 ml, at a flow rate of 1.5 mlrmin . Crude
extract, containing p67-phox, was applied to a Q
Sepharose column HiLoad 16r10, Pharmacia
. Biotech , equilibrated with 20 mM Tris-HCl pH
.7.5 , supplemented with 1 mM dithioerythritol, and
was eluted with a 0–0.5 M NaCl gradient in the same
 .buffer 210 ml, at a flow rate of 1.5 mlrmin .
Purified recombinant proteins were analyzed by
SDS-polyacrylamide gel electrophoresis; p47-phox
was 99% pure, whereas p67-phox was 90% pure.
The proteins were stored at y758C without loss of
activity. Recombinant rac-1 was isolated from E.
coli transformed with rac-1 cDNA subcloned into
the bacterial expression vector pGEX2T a kind gift
.of Dr. Thomas L. Leto , as described by Kwong et al.
w x20 . Briefly, the pellet of bacterial culture, overex-
pressing the glutathione-S-transferase-rac-1 fusion
 .protein, was suspended in 20 mM Tris-HCl pH 7.4 ,
150 mM NaCl, 4 mM MgCl , 1 mM EDTA, 1 mM2
Pefabloc SC, and 10 mgrml leupeptin, and disrupted
by sonication by three pulses of 30 s, using a 250 W
sonicator. The material was centrifuged at 12 000=g
for 5 min and the fusion protein absorbed from the
 .supernatant on glutathione-agarose Sigma . rac-1
was cleaved from the resin-bound fusion protein by
thrombin and, following cleavage, thrombin was re-
moved by absorption on benzamidine-Sepharose 6B
 .Pharmacia Biotech . Purified rac-1 was loaded with
X  .  .guanosine 5 -3-O- thio triphosphate GTPg S , as de-
w xscribed in Ref. 21 , and stored at y758C without
loss of activity.
2.3. Functional assays
In preparation for the generation of an active
NADPH oxidase complex with recombinant cytosolic
components, purified relipidated cytochrome b-559
 wwas diluted in buffer B 65 mM K, Na-phosphate pH
x .7.0 , 1 mM MgCl , and 1 mM EGTA , to a concen-2
tration of 0.2–1 mM. To the cytochrome were added:
a half equimolar amount of FAD in assumption of a
w x1:2 FADrheme ratio 8,22–25 , lithium dodecyl sul-
 .phate LiDS , at a final concentration of 200 mM
 .serving as activator and recombinant p47-phox,
p67-phox and rac-1-GTPg S. Both crude and purified
preparations of recombinant proteins were used, with
identical results. Saturation of cytochrome b-559 with
recombinant proteins required a 1.5-fold molar excess
of p47-phox and p67-phox and a 4- to 5-fold excess
of rac-1-GTPg S. When activation was performed in
Fig. 1. Reaction time course for NADPH upper panel, solid line,
.  .left Y-axis , oxygen upper panel, dotted line, right Y-axis , heme
 .  .middle panel and FAD lower panel during aerobic operation
of the NADPH oxidase complex assembled in vitro. The complex
was generated, as described under Section 2, in a semi-recombi-
nant cell-free system, consisting of 0.2 mM cytochrome b-559,
0.1 mM FAD, and purified recombinant cytosolic components at
the following concentrations: 0.31 mM p47-phox, 0.3 mM p67-
phox, and 1.07 mM rac-1-GTPg S. Assembly was induced by
200 mM LiDS. The reaction was started by the addition of 0.17
 .mM of NADPH arrow marked 1 and completed by reduction
 .with sodium dithionite arrow marked 2 . Tracings are derived
from one characteristic experiment.
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the absence of p47-phox, the remaining two cytosolic
components were present in a molar ratio to cy-
tochrome b-559 of 4:1 to 5:1. Electron transport from
NADPH to oxygen was studied in this system by
repeated fast spectral scanning in the range 366–580
nm, at 1-s intervals, using a diode-array spectro-
 .photometer HP-9452A, Hewlett-Packard . The con-
centration of added NADPH is indicated in the figure
legends. The time course of NADPH, heme, and
flavin oxidoreduction was derived from these spectra,
at the wavelengths of 366, 558 minus 540, and 450
minus 500 nm, respectively. The following extinction
coefficients were used: for NADPH, e was as-366
sumed to be 3.32 mMy1 cmy1, based on the com-
y1 y1 w xmonly accepted value e s3.45 mM cm 26365
and correction for a wavelength shift; for heme b-559,
y1 y1 w xDe s 21.6 mM cm 27 ; for FAD,558-540
y1 y1 w xDe s11.3 mM cm 28 . In situations of450-500
 .low absorbance changes Fig. 1 , averaging of spec-
tral data was used, and oxidoreduction of FAD was
monitored in separate samples of identical composi-
tion by fluorometry at 490“550 nm, to avoid
.interference from excess of NADPH , using a
spectrofluorometer FP-770, Jasco; response time 0.5
.s . Before the initiation of spectroscopic studies, sam-
ples were taken from the reconstituted NADPH oxi-
dase mixtures, for assessing Oy production. This2
was quantified by the initial rate of superoxide dis-
 .mutase SOD -inhibitable cytochrome c reduction,
w xessentially as described before 17 , by adding 5 ml
aliquots of LiDS-activated cell-free mixture to 1 ml
of buffer B, supplemented with 100 mM NADPH
and 2 mM NaN . Upon removal of the samples3
intended for the measurement of Oy production, the2
bulk of the reconstituted NADPH oxidase mixtures
 .was supplemented with SOD 75 Urml and catalase
 .50 Urml , prior to the performance of the electron
transport experiments. When required, oxygen con-
centrations were measured with the microprobe of an
 .oxygen monitor YS153, Yellow Spring Instruments .
Spectra, obtained by diode-array scanning at 1 s
intervals, were digitized at the relevant wavelengths
and difference spectra calculated and transformed
graphically using SigmaPlot, version 2.00 graphing
 .software Jandel .
3. Results and discussion
The kinetic parameters of the semi-recombinant
cell-free system were investigated in the presence of
all three cytosolic components and in a deficient
mixture, lacking p47-phox.
3.1. Kinetics of the complete cell-free system
The time courses of NADPH oxidation, oxygen
consumption and the redox state of the FAD and
heme centers were assessed in the course of the
operation of NADPH oxidase reconstituted in vitro
from purified cytochrome b-599, and recombinant
p47-phox, p67-phox, and rac-1-GTPg S, consequent
to activation by LiDS. As seen in the characteristic
experiment illustrated in Fig. 1, addition of NADPH
 w x.0.17 mM; K f0.03 mM 3 resulted in the rapidm
establishment of a steady-state regime of reaction,
Table 1
Kinetic parameters of steady-state NADPH oxidation in the semi-recombinant cell-free system
2q .  . w x  .Time s Electron flow V , heme mM Pseudo-first-order rate constant Second-order rate constant
X Xy1 2q y1 y1 2q .  . w x  . w x w xmequivrs s k sVr heme M s k sVr heme O2
66 23.0 0.023 1000 4.17=10
67 32.4 0.018 1800 7.50=10
68 36.0 0.019 1894 7.89=10
69 35.4 0.018 1966 8.19=10
610 36.0 0.019 1684 7.02=10
611 35.6 0.018 1977 8.23=10
6 .Mean 33.1"5.1 0.019"0.002 1720"369 7.16"1.53 =10
Presented values correspond to the kinetic tracings shown in Fig. 1. Total heme concentration was 0.20 mM; because of low oxygen
 .consumption less than 20% and accessibility of atmospheric oxygen, an initial oxygen concentration of 0.24 mM was used in
calculations of k.
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with low stationary levels of FAD and heme reduc-
 .tion about 10% for each center , which can be
described by the equation V sVNADPH“ FAD FAD “ heme
w 2qx w xsV sk heme 11 , where k is theheme“ oxygen
pseudo-first-order rate constant for interaction of
heme and oxygen.
Steady-state electron flow, measured as the rate of
NADPH oxidation, was 33.1 mMrs in 1-electron
.equivalents . This corresponds to a turnover value of
165 electronsrhemers 159 electronsrhemers was
y .calculated on the basis of the O production and the2
following rate constants for the heme-oxygen reac-
tion: pseudo-first-order rate constant of 1720 sy1 and
6 y1 y1 second-order constant of 7.16=10 M s de-
.tailed numerical data are shown in Table 1 . The
reaction proceeded until depletion of NADPH Fig.
.  .1 or oxygen checked polarographically ; in the lat-
ter case, flavin and heme centers underwent anaero-
bic reduction. As illustrated in Fig. 2, it was found
that the rates of anaerobic FAD and heme reduction,
after a short aerobic transitional period, amounted to
0.072 and 0.034 mMrs, respectively; therefore, less
than 1% of the aerobic rate. Identical results were
obtained with several batches of purified cytochrome
b-559 and a number of preparations of recombinant
cytosolic components.
The kinetic behaviour of the semi-recombinant
cell-free system is, in part, similar to that recently
w xdescribed by Cross and Curnutte 16 , working with a
cell-free system consisting of cytochrome b-559 and
unfractionated neutrophil cytosol. Thus, the high
turnover values and the low level of heme reduction
are shared by both systems. However, the low level
 .of stationary FAD reduction close to 10% , found in
the semi-recombinant system, contrasts with the 47%
of FAD reduction value reported by Cross and Cur-
w xnutte 16 . The kinetic parameters of the recombinant
cell-free system also differ from those characteristic
of solubilized NADPH oxidase preparations obtained
from PMA-stimulated intact neutrophils, as described
w x w x  .in Refs. 11 and 12 , by the following: a higher
turnover number 165 against 10–15 electronsr
.  .hemers ; b lower level of stationary FAD reduction
 .  .10 against 30–50% , and c higher rate constant of
 y1.heme oxidation by oxygen 1720 against 147 s . In
both solubilized NADPH oxidase preparations de-
w xrived from stimulated intact neutrophils 11,12 and
in the cell-free system containing unfractionated cy-
Fig. 2. Reaction time course for NADPH upper panel, solid line,
.  .left Y-axis , oxygen upper panel, dotted line, right Y-axis , heme
 .  .middle panel and FAD lower panel during aerobic-anaerobic
transition in the NADPH oxidase complex assembled in vitro.
The complex was generated, as described under Section 2, in a
semi-recombinant cell-free system, consisting of 0.99 mM cy-
tochrome b-559, 0.5 mM FAD, and recombinant cytosolic com-
ponents at the following concentrations: 120 mgrml crude ex-
tract of p47-phox, 221 mgrml crude extract of p67-phox, and
3.74 mM purified rac-1-GTPg S. Assembly was induced by 200
mM LiDS. The reaction was started by the addition of 0.80 mM
of NADPH and covering of the cuvette content with paraffin oil
 .arrow marked 1 and completed by reduction with sodium
 .dithionite arrow marked 2 . Tracings are derived from one
characteristic experiment.
w xtosol 16 , the stationary FAD reduction exceeds con-
siderably the level expected in a situation of complete
equilibration with heme, thereby indicating the exis-
tence of a kinetic barrier between the flavin and heme
w xcenters 2,16 . The relatively low level of steady-state
flavin reduction in the present experiments suggests
that in NADPH oxidase reconstituted in the semi-re-
combinant cell-free system, this barrier is partly over-
come.
Another characteristic of the semi-recombinant
cell-free system is a high rate of heme oxidation, with
rate constants exceeding by an order of magnitude
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Fig. 3. Titration with FAD of Oy production by the NADPH2
oxidase complex assembled in vitro. NADPH oxidase complexes,
partially saturated with FAD, were generated as described under
Section 2, at the following concentration of components: 0.11
mM cytochrome b-559, 0.2 mM purified p47-phox, 0.2 mM
purified p67-phox, 1 mM purified rac-1-GTPg S and 200 mM
LiDS. The concentration of FAD was varied from 0.0013 to
0.103 mM. Aliquots of 5 ml were used for the measurement of
Oy producing activity, as described under Section 2. Results2
represent one characteristic experiment.
those of the solubilized enzyme derived from stimu-
w xlated cells 11 . On the other hand, they correspond
w xclosely to the values found by Isogai et al. 29,30 for
the reoxidation of chemically reduced purified cy-
tochrome b-559.
The rate of reduction of NADPH oxidase redox
centers under anaerobiosis is exceeded significantly
by the aerobic turnover of the system, as it was
shown for solubilized oxidase, prepared from stimu-
w xlated cells 10,11 . Therefore, the phenomenon of
oxygen activation is characteristic for the Oy-gener-2
ating NADPH oxidase, independently of the rate of
its functioning. Incomplete anaerobic reduction of
 .redox centers in NADPH oxidase Fig. 2 could be
due to the putatively established heterogeneity of the
w xtwo hemes in cytochrome b-559 25,31 or to the fact
that only part of the cytochrome b-559 molecules
becomes functionally competent upon reconstitution
of the enzyme complex. To examine the last possibil-
ity, we estimated the minimal amount of FAD re-
quired for formation of the active NADPH oxidase
complex by means of titration of Oy-producing activ-2
 .ity with FAD Fig. 3 . These measurements permitted
the estimation of FADrheme ratios and indicated
that 60–80% of cytochrome b-559 was involved in
catalysis assuming a theoretical FADrheme stoi-
w x.chiometry of 0.5 8,22–25 . Obviously, the presence
of a catalytically inactive cytochrome b-559 fraction
in the reconstituted enzyme complex suggests that the
true turnover value of NADPH oxidase is higher than
that established experimentally.
We propose that the electron transfer conditions
existing in the semi-recombinant cell-free system are
more likely to reflect the physiological reality exist-
ing in the intact stimulated cell. Measurements per-
formed on solubilized NADPH oxidase preparations,
derived from stimulated intact cells, are unlikely to
reveal the kinetics of electron transfer prevailing in
vivo, because of the, at least partial, disruption of the
NADPH oxidase complex in the course of the mem-
brane isolation and solubilization procedures. Thus, it
is known that Oy producing activity decays with2
time in the particulate protein isolated from stimu-
w xlated neutrophils 32 and there is good evidence
linking the maintenance of NADPH oxidase activity
to the continuous association between cytosolic com-
w xponents and cytochrome b-559 33 .
3.2. Kinetics of the cell-free system lacking p47-phox
It was proposed that p47-phox and p67-phox have
distinct roles in the induction of electron transfer
w xthrough the redox centers of cytochrome b-559 16 .
w x w xFreeman and Lambeth 34 and we 35 have recently
found that Oy production can be elicited in a semi-2
recombinant cell-free system lacking p47-phox.
Turnover rates of up to 60 mol Oyrsrmol cy-2
tochrome b-559 could be achieved provided that
p67-phox and rac-1-GTPg S were present in marked
w xmolar excesses in relation to cytochrome b-559 35 .
No Oy production could be induced by single cy-2
tosolic components or any combination of two cy-
tosolic components, other than p67-phox and rac-1-
w xGTPg S. Cross and Curnutte 16 studied the steady-
state reduction of FAD and heme in mixtures of
purified relipidated and reflavinated cytochrome b-
559 and cytosols of chronic granulomatous disease
 .CGD patients, deficient in either p47-phox or p67-
phox, activated by sodium dodecyl sulphate. They
found no evidence of heme reduction when using
either of the two deficient cytosols; however, p47-
phox-deficient, but not p67-phox-deficient cytosol,
elicited reduction of 32% of FAD, leading to the
conclusion that p67-phox is capable of inducing elec-
( )V. Koshkin et al.rBiochimica et Biophysica Acta 1319 1997 139–146 145
tron flow from NADPH to FAD but not from FAD to
w xheme 16 .
We, therefore, extended our studies to the analysis
of electron transfer in the semi-recombinant cell-free
system lacking p47-phox. The preparations of cy-
tochrome b-559, p67-phox and rac-1, used in these
experiments, were found to be free of contamination
by p47-phox, as assessed by immunoblotting and
enzyme-linked immunosorbent assay with a poly-
clonal antibody to p47-phox gift of Dr. Thomas L.
. w xLeto 35 . The concentrations of recombinant cytoso-
lic components were chosen to assure molar ratios in
relation to cytochrome b-559 of at least 4 to 1.
Addition of NADPH to the mixture consisting of
purified cytochrome b-559, recombinant p67-phox
and rac-1-GTPg S, FAD and an optimized concentra-
tion of LiDS, resulted in the rapid establishment of a
steady-state regime of reaction, characterized by low
stationary levels of FAD and heme reduction ap-
.proximately 10%, for each center , similar to that
 .found in the complete cell-free system Fig. 4 .
Steady-state electron flow, assessed by the rate of
NADPH oxidation, was 49 mMrs in 1-electron
.equivalents , corresponding to a turnover value of 83
electronsrhemers and a pseudo-first-order rate con-
stant for the heme-oxygen reaction of 1455 sy1. The
reaction proceeded until depletion of oxygen, when
flavin and heme centers underwent anaerobic reduc-
tion. These results differ from those reported by
w xCross and Curnutte 16 , based on somewhat different
experimental conditions, by the detection of heme
reduction, a lower level of FAD reduction, and, most
significantly, by a significant electron flow beyond
the flavin center, resulting in the production of Oy.2
In our hands, the p47-phox-deficient system differed
from the complete system principally by a lower by
.50% turnover number but otherwise behaved like a
slower functioning version of it. The kinetic charac-
teristics of the p47-phox-deficient system, as de-
scribed in the present report, as well as its recently
reported ability to generate significant amounts of
y w xO 34,35 , are in accordance with the mild clinical2
course of disease in patients with the p47-phox-defi-
w xcient form of CGD 36 and with the detection, in
their phagocytes, of a certain level of intracellular
w x w xoxidant production 16 . As proposed recently 34,35 ,
our results are best explained by p67-phox and rac-1
being both required and sufficient for the induction of
Fig. 4. Reaction time course for NADPH upper panel, solid line,
.  .left Y-axis , oxygen upper panel, dotted line, right Y-axis , heme
 .  .middle panel and FAD lower panel during aerobic and anaero-
bic operation of the NADPH oxidase complex assembled in the
absence of p47-phox. The complex was generated, as described
under Section 2, in a semi-recombinant cell-free system, consist-
ing of 0.59 mM cytochrome b-559, 1.01 mM FAD, 2.47 mM
purified p67-phox, and 2.74 mM purified rac-1-GTPg S. Assem-
bly was induced by 180 mM LiDS and the reaction was started
by the addition of 0.85 mM of NADPH and covering of the
 .cuvette content with paraffin oil arrow marked 1 . After reaching
the anaerobic state, 15 ml of oxygen-saturated medium was
 .added arrow marked 2 , and, finally, the system was reduced
 .with sodium dithionite arrow marked 3 . Tracings are derived
from one characteristic experiment.
electron flow from NADPH to oxygen, through both
redox centers. Our findings support the proposal by
w xCross and Curnutte 16 that p67-phox induces elec-
tron flow from NADPH to FAD but are not in
agreement with the hypothesis that p47-phox is re-
quired for electron transport to proceed from FAD to
heme and, subsequently, to oxygen.
In conclusion, the kinetic behaviour of the highly
active NADPH oxidase assembled in vitro from puri-
fied cytochrome b-559 and recombinant cytosolic
components differs from the kinetic patterns of both
the enzyme solubilized from the membrane of stimu-
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w xlated cells 11,12 and the cell-free system containing
w xunfractionated cytosol 16 . The present system ex-
hibits a significantly lower stationary level of FAD
reduction and an increased, by an order of magnitude,
rate constant of heme oxidation. This indicates that
the distinctive kinetic features of NADPH oxidase
reconstituted in vitro from purified cytochrome b-559
and recombinant cytosolic components are the lower-
ing of the kinetic barrier between flavin and heme
and the acceleration of heme-oxygen interaction.
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